Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Azithromycin: an interim analysis.

A P Ball1

  • 1Infectious Diseases Unit, Cameron Hospital, Windygates, UK.

The Journal of International Medical Research
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Azithromycin, a new azalide antibiotic, shows effectiveness against Gram-positive and some Gram-negative bacteria like Haemophilus influenzae. Clinical trials confirm its efficacy and tolerability for various infections with short-course, once-daily dosing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Journal of chemotherapy (Florence, Italy)·2004
Same author

Acute liver injury associated with amoxicillin-clavulanic acid.

Archives of internal medicine·1997
Same author

Lower respiratory tract infection therapy--the role of ciprofloxacin.

The Journal of international medical research·1995
Same author

Dental prophylaxis for endocarditis.

Lancet (London, England)·1992
Same author

Antibiotic prophylaxis and infective endocarditis.

Lancet (London, England)·1992
Same author

Case against antibiotic prophylaxis for dental treatment of patients with joint prostheses.

Lancet (London, England)·1992
Same journal

Platelet-to-albumin ratio and postoperative bleeding after endovascular treatment of intracranial aneurysms: A retrospective cohort study.

The Journal of international medical research·2026
Same journal

Determinants of cleft lip and cleft palate in Ethiopian children: Insights from a hospital-based study using Bayesian modeling.

The Journal of international medical research·2026
Same journal

Etiology, surgical management, and outcomes of patients with scleral thinning.

The Journal of international medical research·2026
Same journal

Hemichorea associated with nonketotic hyperglycemia: A case report with unremarkable neuroimaging at presentation.

The Journal of international medical research·2026
Same journal

Diagnostic performance of machine learning-based radiomics models for predicting epidermal growth factor receptor mutation status in lung adenocarcinoma in Chinese patients: A systematic review and meta-analysis.

The Journal of international medical research·2026
Same journal

Postlumbar puncture spinal intradural hematoma: A case report and literature review.

The Journal of international medical research·2026
See all related articles

Area of Science:

  • Pharmacology
  • Microbiology
  • Clinical Medicine

Background:

  • Azithromycin is a novel azalide antibiotic related to erythromycin.
  • In vitro studies indicate broad-spectrum activity against Gram-positive and certain Gram-negative pathogens.

Purpose of the Study:

  • To review clinical trials evaluating azithromycin's efficacy and tolerability.
  • To assess the suitability of short-course, once-daily azithromycin regimens for common bacterial infections.

Main Methods:

  • Review of clinical trial data for azithromycin treatment regimens.
  • Evaluation of in vitro antimicrobial activity and pharmacokinetic properties.

Main Results:

  • Azithromycin demonstrates comparable activity to erythromycin against Gram-positive bacteria.

Related Experiment Videos

  • Enhanced activity against specific Gram-negative bacteria, including Haemophilus influenzae.
  • Excellent tissue penetration and prolonged elimination half-life support short-course therapy.

    • Conclusions:

    • Azithromycin is clinically and bacteriologically effective for respiratory tract, skin, and soft tissue infections.
    • Short-course, once-daily azithromycin regimens are well-tolerated compared to standard antibiotic treatments.